Cite
HARVARD Citation
Braun, J. et al. (n.d.). OP0001 Effect of Secukinumab, An Interleukin-17a Inhibitor, on Spinal Radiographic Changes through 2 Years in Patients with Active Ankylosing Spondylitis: Results of The Phase 3 Study, Measure 1. Annals of the rheumatic diseases. p. 52. [Online].